Renalyx Health Systems Profile
Key Indicators
- Authorised Capital ₹ 9.37 Cr
as on 16-11-2024
- Paid Up Capital ₹ 9.25 Cr
as on 16-11-2024
- Company Age 12 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 Cr
as on 16-11-2024
- Revenue -97.45%
(FY 2023)
- Profit -217.90%
(FY 2023)
- Ebitda -255.04%
(FY 2023)
- Net Worth -114.47%
(FY 2023)
- Total Assets -37.51%
(FY 2023)
About Renalyx Health Systems
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.37 Cr and a paid-up capital of Rs 9.25 Cr.
The company currently has active open charges totaling ₹4.00 Cr.
Shyam Vasudevarao and Anurag Srivastava serve as directors at the Company.
- CIN/LLPIN
U74140KA2012PTC066472
- Company No.
066472
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Oct 2012
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Renalyx Health Systems Private Limited offer?
Renalyx Health Systems Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Treatment Services, Patient Monitoring System, Computer and Mobile Softwares & Apps, ERP Packages.
Who are the key members and board of directors at Renalyx Health Systems?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shyam Vasudevarao  | Managing Director | 29-Feb-2016 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anurag Srivastava | Director | 04-Feb-2021 | Current |
Financial Performance and Corporate Structure Insights of Renalyx Health Systems.
Renalyx Health Systems Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 97.45% decrease. The company also saw a substantial fall in profitability, with a 217.9% decrease in profit. The company's net worth observed a substantial decline by a decrease of 114.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Renalyx Health Systems?
In 2023, Renalyx Health Systems had a promoter holding of 51.04% and a public holding of 48.96%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Maastricht Education And Research Centre Private LimitedActive 15 years 3 monthsShyam Vasudevarao is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Mar 2017 | ₹4.00 Cr | Open |
How Many Employees Work at Renalyx Health Systems?
Unlock and access historical data on people associated with Renalyx Health Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Renalyx Health Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Renalyx Health Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
